CA2473814A1 - Methode et marqueurs de diagnostic des maladies renales - Google Patents

Methode et marqueurs de diagnostic des maladies renales Download PDF

Info

Publication number
CA2473814A1
CA2473814A1 CA 2473814 CA2473814A CA2473814A1 CA 2473814 A1 CA2473814 A1 CA 2473814A1 CA 2473814 CA2473814 CA 2473814 CA 2473814 A CA2473814 A CA 2473814A CA 2473814 A1 CA2473814 A1 CA 2473814A1
Authority
CA
Canada
Prior art keywords
marker
polypeptide
diabetes
disease
probability
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA 2473814
Other languages
English (en)
Inventor
Harald Mischak
Thorsten Kaiser
Stefan Wittke
Michael Walden
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Mosaiques Diagnostics and Therapeutics AG
Original Assignee
Mosaiques Diagnostics and Therapeutics AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mosaiques Diagnostics and Therapeutics AG filed Critical Mosaiques Diagnostics and Therapeutics AG
Priority to CA 2473814 priority Critical patent/CA2473814A1/fr
Publication of CA2473814A1 publication Critical patent/CA2473814A1/fr
Abandoned legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • G01N33/6896—Neurological disorders, e.g. Alzheimer's disease
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/34—Genitourinary disorders
    • G01N2800/347—Renal failures; Glomerular diseases; Tubulointerstitial diseases, e.g. nephritic syndrome, glomerulonephritis; Renovascular diseases, e.g. renal artery occlusion, nephropathy
CA 2473814 2004-07-13 2004-07-13 Methode et marqueurs de diagnostic des maladies renales Abandoned CA2473814A1 (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CA 2473814 CA2473814A1 (fr) 2004-07-13 2004-07-13 Methode et marqueurs de diagnostic des maladies renales

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CA 2473814 CA2473814A1 (fr) 2004-07-13 2004-07-13 Methode et marqueurs de diagnostic des maladies renales

Publications (1)

Publication Number Publication Date
CA2473814A1 true CA2473814A1 (fr) 2006-01-13

Family

ID=35610390

Family Applications (1)

Application Number Title Priority Date Filing Date
CA 2473814 Abandoned CA2473814A1 (fr) 2004-07-13 2004-07-13 Methode et marqueurs de diagnostic des maladies renales

Country Status (1)

Country Link
CA (1) CA2473814A1 (fr)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2007063090A1 (fr) * 2005-11-30 2007-06-07 Mosaiques Diagnostics And Therapeutics Ag Marqueur polypeptidique pour diagnostiquer et evaluer la stenose du meat de l'uretre
WO2008110593A2 (fr) * 2007-03-14 2008-09-18 Mosaiques Diagnostics And Therapeutics Ag Procédé et marqueurs pour le diagnostic de maladies rénales
WO2023061241A1 (fr) * 2021-10-14 2023-04-20 深圳市陆为生物技术有限公司 Marqueur de diagnostic de lymphocytes t pour une néphropathie d'immunoglobuline a

Cited By (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2007063090A1 (fr) * 2005-11-30 2007-06-07 Mosaiques Diagnostics And Therapeutics Ag Marqueur polypeptidique pour diagnostiquer et evaluer la stenose du meat de l'uretre
WO2008110593A2 (fr) * 2007-03-14 2008-09-18 Mosaiques Diagnostics And Therapeutics Ag Procédé et marqueurs pour le diagnostic de maladies rénales
EP1972940A1 (fr) * 2007-03-14 2008-09-24 mosaiques diagnostics and therapeutics AG Procédé et marqueur destinés à diagnostiquer des maladies des reins
WO2008110593A3 (fr) * 2007-03-14 2008-11-13 Mosaiques Diagnostics & Therap Procédé et marqueurs pour le diagnostic de maladies rénales
JP2010521000A (ja) * 2007-03-14 2010-06-17 モザイクヴェス ディアグノシュティクス アンド テラポイティクス アクチェン ゲゼルシャフト 腎疾患の診断のための方法およびマーカー
WO2023061241A1 (fr) * 2021-10-14 2023-04-20 深圳市陆为生物技术有限公司 Marqueur de diagnostic de lymphocytes t pour une néphropathie d'immunoglobuline a

Similar Documents

Publication Publication Date Title
AU2006336091B2 (en) Method and markers for the diagnosis of renal diseases
US8389222B2 (en) Apolipoprotein fingerprinting technique and methods related thereto
US20060286602A1 (en) Method and markers for the diagnosis of renal diseases
EP3232198A1 (fr) Biomarqueur pour le diagnostic de l'hépatome et son utilisation
JP2011501133A (ja) 心血管または脳血管主要有害事象を検出するための方法
US7297556B2 (en) Method of diagnosing nephrotic syndrome
JP2009500641A (ja) 多発性硬化症の診断方法
JP2005510575A (ja) アルツハイマー病を予測するｉｇ重鎖、ｉｇカッパ、ｉｇラムダバイオポリマーマーカー
Pinet et al. Predicting left ventricular remodeling after a first myocardial infarction by plasma proteome analysis
US20060088830A1 (en) Protein biomarkers that distinguish prostate cancer from non-malignant cells
KR101390543B1 (ko) 췌장암 진단용 마커 및 이의 용도
CA2473814A1 (fr) Methode et marqueurs de diagnostic des maladies renales
KR20080091234A (ko) 신장 질환의 진단 방법 및 이를 위한 마커
JP2005510721A (ja) アルツハイマー病を予測するｉｇラムダバイオポリマーマーカー
JP2005510718A (ja) Ｉｉ型糖尿病を予測する補体ｃ３前駆体バイオポリマーマーカー
JP2005510731A (ja) Ｉｉ型糖尿病のスクリーニングのためのフィブリノゲンバイオポリマーマーカーおよびその使用
CA2525740A1 (fr) Biomarqueurs permettant d'effectuer un diagnostic differentiel de la pancreatite et du cancer du pancreas
KR102131860B1 (ko) 아르기닌이 메틸화된 ggt1에 특이적으로 결합하는 대장암 진단용 바이오마커 조성물
JP2005523420A (ja) アルツハイマー病を示す補体ｃ３前駆体バイオポリマーマーカー
US20060105367A1 (en) Method and markers for the diagnosis of Graft versus Host Disease (GvHD)
KR101819939B1 (ko) 유방암 진단용 단백질 마커 베타-투 마이크로글로불린 및 이를 검출하는 방법
JP2005523419A (ja) インスリン耐性を示すフィブロネクチンおよびフィブリノゲンバイオポリマーマーカー
JP2005525535A (ja) インスリン耐性を示すマクログロブリンバイオポリマーマーカー
CN114137225A (zh) 一种原发性抑郁症的血清多肽诊断分子组合物及其应用
JP2005510727A (ja) アルツハイマー病を予測するｈｐおよびアポリポタンパク質バイオポリマーマーカー

Legal Events

Date Code Title Description
EEER Examination request
FZDE Dead

Effective date: 20160713